Search

Your search keyword '"Wang, Xicheng"' showing total 1,288 results

Search Constraints

Start Over You searched for: Author "Wang, Xicheng" Remove constraint Author: "Wang, Xicheng"
1,288 results on '"Wang, Xicheng"'

Search Results

2. Camrelizumab plus famitinib in previously chemo-immunotherapy treated patients with advanced NSCLC: results from an open-label multicenter phase 2 basket study

3. Flow Reconstruction of Single-Phase Planar Jet from Sparse Temperature Measurements

4. Long-term survivals of immune checkpoint inhibitors as neoadjuvant and adjuvant therapy in dMMR/MSI-H colorectal and gastric cancers

5. Basic Design and Implementation Steps for Cross-sectional Studies in General Practice and Primary Care

10. Publisher Correction: A postnatal network of co-hepato/pancreatic stem/progenitors in the biliary trees of pigs and humans

11. A postnatal network of co-hepato/pancreatic stem/progenitors in the biliary trees of pigs and humans

12. Efficacy, safety and pharmacokinetics of Unecritinib (TQ-B3101) for patients with ROS1 positive advanced non-small cell lung cancer: a Phase I/II Trial

15. Garsorasib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 2 trial

21. Chinese expert consensus on the pelvic exenteration for primary rectal cancer beyond total mesorectal excision planes and locally recurrent rectal cancer

29. Research on Equivalent Acceleration Method of Body-in-White Endurance Test

30. Research on the Influence of Drive Shafts Angles on Vehicle Lateral Swing

32. Oral VV116 versus placebo in patients with mild-to-moderate COVID-19 in China: a multicentre, double-blind, phase 3, randomised controlled study

46. Encorafenib and cetuximab versus irinotecan/cetuximab or FOLFIRI/cetuximab in Chinese patients with BRAF V600E mutant metastatic colorectal cancer: The NAUTICAL CRC study.

47. A simple, feasible, efficient and safe treatment strategy of sofosbuvir/velpatasvir for chronic HCV/HIV-1 coinfected patients regardless of HCV genotypes: a multicenter, open-label study in China

48. D-1553 (Garsorasib), a Potent and Selective Inhibitor of KRASG12C in Patients With NSCLC: Phase 1 Study Results

50. (5R)-5-hydroxytriptolide for HIV immunological non-responders receiving ART: a randomized, double-blinded, placebo-controlled phase II study

Catalog

Books, media, physical & digital resources